✦ LIBER ✦

O116 Does aspirin interfere with the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in systolic chronic heart failure?: Analysis of the EMPHASIS-HF study

✍ Scribed by Krum, Henry; Pitt, Bertram; McMurray, John; Swedberg, Karl; van Veldhuisen, Dirk; Pocock, Stuart; Collier, Tim; Vincent, John; Turgonyi, Eva; Zannad, Faiez

Book ID: 122154963
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 252 KB
Volume: 9
Category: Article
ISSN: 2211-8160
DOI: 10.1016/j.gheart.2014.03.1327

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence, Determinants, and Prognostic

Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy: Results From the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)

✍ Rossignol, P.; Dobre, D.; McMurray, J. J. V.; Swedberg, K.; Krum, H.; van Veldhu 📂 Article 📅 2014 🏛 Ovid Technologies Wolters Kluwer -American Heart A 🌐 English ⚖ 786 KB